Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Transfusion

• Publication date

  2018-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/trf.14588PMID 29570817PMCID PMC7193458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease

  2015cited by this paper
• Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease

  2014cited by this paper
• A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease.

  2014cited by this paper
• Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models

  2014cited by this paper
• Cost‐effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients

  2014cited by this paper
• Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

  2014cited by this paper
• Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City

  2014cited by this paper
• Red blood cell alloimmunization in sickle cell disease: prevalence in 2010

  2013cited by this paper
• High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

  2013cited by this paper
• Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease

  2013cited by this paper
• Red cell exchange does not appear to increase the rate of allo‐ and auto‐immunization in chronically transfused children with sickle cell disease

  2011cited by this paper
• Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14‐year experience from a single center (CME)

  2011cited by this paper
• Detection of anti‐D in D– recipients transfused with D+ red blood cells

  2007cited by this paper
• Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity

  2006cited by this paper
• Mailing of a sickle cell disease educational packet increases blood donors within an African American community

  2006cited by this paper
• Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study

  2005cited by this paper
• Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories.

  2005cited by this paper
• WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization

  2003cited by this paper
• Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

  2002cited by this paper
• Guidelines on the clinical use of leucocyte‐depleted blood components

  1998cited by this paper
• Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.

  1990cited by this paper
• Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.

  1990cited by this paper

• Red blood cell alloimmunization after hematopoietic stem cell transplant: Clinical challenges and implications for donor and recipient—A case report

  2025cites this paper
• CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion

  2025cites this paper
• Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines

  2024influential citation
• Development of Non-ABO Red Blood Cell Alloantibodies in Patient Undergoing Allogeneic Haematopoietic Stem Cell Transplant

  2024cites this paper
• Dynamics of antibody engagement of red blood cells in vivo and in vitro

  2024cites this paper
• The Growing Challenge of RBC Alloimmunization in the Management of Patients with Sickle Cell Disease.

  2023cites this paper
• Red Blood Cell Alloimmunizations in Thalassaemia Patients With Regular Transfusion in China: a Systematic Review and Meta-Analysis.

  2023cites this paper
• Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries.

  2023cites this paper
• How do we operate a large monthly red blood cell exchange program

  2023cites this paper
• Polymorphisms in the promoter regions of RHD and RHCE genes in the Chinese Han population

  2023cites this paper
• Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunization

  2023cites this paper
• Algorithm‐based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease

  2022cites this paper
• Transfusion Practice, Post-Transfusion Complications and Risk Factors in Sickle Cell Disease in Senegal, West Africa

  2022cites this paper
• Prevalence of alloimmunization against red blood cells antigens in sickle cell disease patients in Latakia, Syria.

  2022cites this paper
• Associations between alloantibodies and multiple red blood cell transfusions in patients with sickle cell anemia

  2022cites this paper
• An overview of red blood cell and platelet alloimmunisation in transfusion.

  2022cites this paper
• The Development and Consequences of Red Blood Cell Alloimmunization

  2022cites this paper
• Post–hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics

  2021cites this paper
• Antibody incidence and red blood cell transfusions in patients on daratumumab

  2021cites this paper
• Rate of RhD‐alloimmunization after the transfusion of multiple RhD‐positive primary red blood cell‐containing products

  2021cites this paper
• One third of alloantibodies in patients with sickle cell disease transfused with African blood are missed by the standard red blood cell test panel

  2021cites this paper
• RHD and RHCE molecular analysis in weak D blood donors and in patients with Rh antibodies against their own corresponding Rh antigen.

  2020influential citation
• Alloimmunization in Chronically Transfused Patients and Those With Malignancies

  2020cites this paper
• Mechanisms of alloimmunization in sickle cell disease.

  2019cites this paper
• SICKLE CELL DISEASE: BACKGROUND AND MANAGEMENT

  2018cites this paper
• Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine

  2018cites this paper